2019
DOI: 10.18203/2320-6012.ijrms20192473
|View full text |Cite
|
Sign up to set email alerts
|

Clinical profile and lipid abnormalities in subclinical and overt primary hypothyroidism

Abstract: Background: Overt and subclinical hypothyroidism, affects metabolism of lipids particularly that of cholesterol, low density lipoprotein and triglyceride. Hypercholesterolemia predisposes to atherosclerosis and thereby increases cardiovascular risks.Methods: Hundred patients of primary  hypothyroidism of age more than 15 yrs were included. Five milliliters of venous blood was drawn in fasting state and serum obtained; thyroid function test (TFT) and fasting lipid profile were performed. Based on the TFT, patie… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 12 publications
1
0
0
Order By: Relevance
“…The levels of total cholesterol, triglyceride, and LDL-C were higher in the hypothyroid patients which might be due to inhibition of hepatic low-density lipoprotein (LDL) receptors and cholesterol alpha-monooxygenase activity, resulting in decreased clearance of LDL and total cholesterol [ 26 ]. Similar dyslipidemia patterns have recently been reported in conjunction with the current research [ 27 , 28 ]. The decrease in clearance of LDL and total cholesterol in hypothyroid patients might be due to binding of T3 with the sterol regulatory element binding proteins (SREBP), which upregulate the synthesis of LDL receptors along with the regulatory enzymes of cholesterol synthesis, i.e., hydroxymethyl glutaryl CoA (HMG CoA).…”
Section: Discussionsupporting
confidence: 92%
“…The levels of total cholesterol, triglyceride, and LDL-C were higher in the hypothyroid patients which might be due to inhibition of hepatic low-density lipoprotein (LDL) receptors and cholesterol alpha-monooxygenase activity, resulting in decreased clearance of LDL and total cholesterol [ 26 ]. Similar dyslipidemia patterns have recently been reported in conjunction with the current research [ 27 , 28 ]. The decrease in clearance of LDL and total cholesterol in hypothyroid patients might be due to binding of T3 with the sterol regulatory element binding proteins (SREBP), which upregulate the synthesis of LDL receptors along with the regulatory enzymes of cholesterol synthesis, i.e., hydroxymethyl glutaryl CoA (HMG CoA).…”
Section: Discussionsupporting
confidence: 92%